Cambridge's Enumeral Filed for Bankruptcy, Sells Assets to Bay Area's XOMA Post author:Sam Post published:February 6, 2018 Post category:BioPharma It’s the end of the road for Cambridge, MA based Enumeral Biomedical. Source: BioSpace You Might Also Like Global Med Device Leader Anthrex Reveals Big Expansion Plans November 9, 2017 AstraZeneca Canada Release: Pan-Canadian Oncology Drug Review Recommendation Supports The Use Of Tagrisso (Osimertinib) As The Standard Of Care For T790M Mutated Non-Small Cell Lung Cancer May 7, 2017 ITUS Pushes CAR-T Program for Solid Tumors, Develops Early Cancer Detection Platform November 28, 2017
AstraZeneca Canada Release: Pan-Canadian Oncology Drug Review Recommendation Supports The Use Of Tagrisso (Osimertinib) As The Standard Of Care For T790M Mutated Non-Small Cell Lung Cancer May 7, 2017
ITUS Pushes CAR-T Program for Solid Tumors, Develops Early Cancer Detection Platform November 28, 2017
